- Filed
- May 16, 2025 12:00 AM ET
- Period of report
- —
Restated figures. One or more values in this filing restate previously reported amounts.
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q1 2025 · Apr 30, 2025 | 21.55M sh |
| Cash And Equivalents | Q1 2025 · Dec 31, 2024 | $135 |
| Cash And Equivalents | Q1 2025 · Sep 30, 2024 | $716 |
| Current Liabilities | Q1 2025 · Dec 31, 2024 | $5.87M |
| Current Liabilities | Q1 2025 · Sep 30, 2024 | $5.38M |
| Total Liabilities | Q1 2025 · Dec 31, 2024 | $5.87M |
| Total Liabilities | Q1 2025 · Sep 30, 2024 | $5.38M |
| Current Assets | Q1 2025 · Dec 31, 2024 | $173.68K |
| Current Assets | Q1 2025 · Sep 30, 2024 | $143.35K |
| Total Assets | Q1 2025 · Dec 31, 2024 | $191.42K |
| Total Assets | Q1 2025 · Sep 30, 2024 | $161.08K |
| Shares Diluted | Q1 2025 · Dec 31, 2023 | 3.6M sh |
| Operating Cash Flow | Q1 2025 · Dec 31, 2023 | −$162.34K |
| Stockholders Equity restated | Q1 2025 · Dec 31, 2023 | −$5.24M |
| Stockholders Equity restated | Q1 2025 · Sep 30, 2023 | −$5.1M |
| Eps Diluted restated | Q1 2025 · Dec 31, 2023 | −$0.04 |
| Eps Basic restated | Q1 2025 · Dec 31, 2023 | −$0.04 |
| Rd Expense | Q1 2025 · Dec 31, 2023 | $47.53K |
| Net Income restated | Q1 2025 · Dec 31, 2023 | −$144.93K |
| Operating Income | Q1 2025 · Dec 31, 2023 | −$122.78K |
| Revenue | Q1 2025 · Dec 31, 2023 | $59.07K |